During the past decade, Centre Azureen De Cancerologie; Cons externes conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 5 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centre Azureen De Cancerologie; Cons externes" are "Breast Neoplasms" (2 trials), "Colorectal Cancer" (2 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Centre Azureen De Cancerologie; Cons externes" in a lesser frequency.

Most popular intervention types in "Centre Azureen De Cancerologie; Cons externes" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Trastuzumab" (2 trials), "Bevacizumab" (1 trials), "Docetaxel" (1 trials), "Herceptin" (1 trials) and "Nab-paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Azureen De Cancerologie; Cons externes" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Centre Azureen De Cancerologie; Cons externes". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Centre Azureen De Cancerologie; Cons externes, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre Azureen De Cancerologie; Cons externes, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Centre Azureen De Cancerologie; Cons externes has several departments that took part in Clinical trials: "Institut Arnault Tzanck; Medecine I Gastro Enterologie" - 2 trials